HeartBeam, Inc. announced the appointment of Peter J. Fitzgerald, MD, PhD, as Chief Medical Officer. In addition to his world-renowned expertise in interventional cardiology, Dr. Fitzgerald is an accomplished inventor, entrepreneur, and investment fund founder. Dr. Fitzgerald is the Director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School.

He is an interventional cardiologist and holds a PhD in electrical engineering. Dr. Fitzgerald is Professor Emeritus in the Departments of Medicine (Cardiology) at Stanford University and has led or participated in over 175 clinical trials, published over 650 manuscripts/chapters, and lectures worldwide. Over the past two decades, he has trained over 150 post-doctoral candidates in engineering and medicine.

Dr. Fitzgerald has been principle and founder of 24 medical device companies in the San Francisco Bay area, transitioning 18 of these start-ups to medium/large-cap life science companies. In 2009, he co-founded TriVentures, an Israeli-based incubator/venture fund for early-stage medical technology and digital health. He has also been a consultant to the US Food and Drug Administration for the past 20 years, focused on medical technology and data driven health analytics.